Ching‐Lan Cheng

3.3k total citations · 2 hit papers
53 papers, 2.3k citations indexed

About

Ching‐Lan Cheng is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Ching‐Lan Cheng has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 13 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Ching‐Lan Cheng's work include Venous Thromboembolism Diagnosis and Management (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Acute Ischemic Stroke Management (6 papers). Ching‐Lan Cheng is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Acute Ischemic Stroke Management (6 papers). Ching‐Lan Cheng collaborates with scholars based in Taiwan, United States and China. Ching‐Lan Cheng's co-authors include Yea‐Huei Kao Yang, Cheng‐Han Lee, Swu‐Jane Lin, Cheng‐Han Lee, Li-Jen Lin, Chih‐Ling Huang, Ju‐Yi Chen, Chin E. Lin, Yufen Yang and Chi‐Ho Lee and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Clinical Pharmacology & Therapeutics.

In The Last Decade

Ching‐Lan Cheng

48 papers receiving 2.3k citations

Hit Papers

Validation of the national health insurance research data... 2010 2026 2015 2020 2010 2015 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching‐Lan Cheng Taiwan 18 727 463 463 269 261 53 2.3k
Cheng‐Han Lee Taiwan 18 675 0.9× 457 1.0× 521 1.1× 431 1.6× 99 0.4× 64 2.4k
Stephen S. Johnston United States 28 989 1.4× 748 1.6× 329 0.7× 167 0.6× 213 0.8× 135 3.2k
Jawad H. Butt Denmark 27 1.3k 1.8× 335 0.7× 557 1.2× 262 1.0× 102 0.4× 192 2.7k
Jianhua Wu United Kingdom 33 736 1.0× 258 0.6× 455 1.0× 195 0.7× 90 0.3× 159 3.2k
Daniel Caldeira Portugal 30 1.4k 1.9× 469 1.0× 582 1.3× 451 1.7× 473 1.8× 172 3.0k
Aurelio Cayuela Spain 30 615 0.8× 487 1.1× 1.0k 2.2× 676 2.5× 290 1.1× 228 3.4k
Kevin He United States 18 585 0.8× 514 1.1× 300 0.6× 302 1.1× 169 0.6× 111 2.5k
Cornelis Boersma Netherlands 17 589 0.8× 416 0.9× 246 0.5× 243 0.9× 131 0.5× 78 2.5k
Meredith Akerman United States 26 422 0.6× 666 1.4× 540 1.2× 197 0.7× 185 0.7× 170 2.4k
Cheng‐Yang Hsieh Taiwan 16 399 0.5× 191 0.4× 497 1.1× 201 0.7× 83 0.3× 63 1.8k

Countries citing papers authored by Ching‐Lan Cheng

Since Specialization
Citations

This map shows the geographic impact of Ching‐Lan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Lan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Lan Cheng more than expected).

Fields of papers citing papers by Ching‐Lan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Lan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Lan Cheng. The network helps show where Ching‐Lan Cheng may publish in the future.

Co-authorship network of co-authors of Ching‐Lan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Lan Cheng. A scholar is included among the top collaborators of Ching‐Lan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Lan Cheng. Ching‐Lan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Ching‐Lan, et al.. (2025). A Nationwide Cohort Study on Antidepressant Use and Stroke Risk in Young Adults Aged 18–44 Years. Clinical Therapeutics. 47(9). 720–728.
3.
4.
Cheng, Ching‐Lan, et al.. (2022). Sex difference in heart failure risk associated with febuxostat and allopurinol in gout patients. Frontiers in Cardiovascular Medicine. 9. 891606–891606. 3 indexed citations
5.
Sato, Tsugumichi, Ching‐Lan Cheng, Heung‐Woo Park, et al.. (2020). Real‐world evidence of population differences in allopurinol‐related severe cutaneous adverse reactions in East Asians: A population‐based cohort study. Clinical and Translational Science. 14(3). 1002–1014. 9 indexed citations
6.
Cheng, Ching‐Lan, et al.. (2018). Detecting Potential Adverse Drug Reactions Using a Deep Neural Network Model. Journal of Medical Internet Research. 21(2). e11016–e11016. 86 indexed citations
7.
Sheu, Shwu‐Jiuan, et al.. (2018). Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan. BMC Health Services Research. 18(1). 638–638. 7 indexed citations
8.
Lee, Cheng‐Han, Ting‐Hsing Chao, Ching‐Lan Cheng, et al.. (2016). Efficacy and safety of ticagrelor versus clopidogrel in acute coronary syndrome in Taiwan: A multicenter retrospective pilot study. Journal of the Chinese Medical Association. 79(10). 521–530. 33 indexed citations
9.
Hsu, Jason C., Dennis Ross‐Degnan, Anita K. Wagner, et al.. (2015). Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies. Journal of Pharmaceutical Policy and Practice. 8(1). 9 indexed citations
10.
Cheng, Ching‐Lan, et al.. (2015). Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan. International Journal of Cardiology. 201. 96–101. 244 indexed citations breakdown →
11.
Cheng, Ching‐Lan, et al.. (2013). Utilization patterns of Antihyperuricemic Agents Following Safety Announcement on Allopurinol and Benzbromarone by Taiwan Food and Drug Administration. Pharmacoepidemiology and Drug Safety. 23(3). 309–313. 7 indexed citations
12.
Chang, Chia‐Hsien, et al.. (2012). Risk of Insomnia Attributable to β-Blockers in Elderly Patients with Newly Diagnosed Hypertension. Drug Metabolism and Pharmacokinetics. 28(1). 53–58. 13 indexed citations
13.
Lee, Chi‐Ho, Ching‐Lan Cheng, Chia‐Hsien Chang, et al.. (2011). Universal pharmacological thromboprophylaxis for total knee arthroplasty may not be necessary in low‐risk populations: a nationwide study in Taiwan. Journal of Thrombosis and Haemostasis. 10(1). 56–63. 18 indexed citations
14.
Lee, Chi‐Ho, Lin Li, Ching‐Lan Cheng, et al.. (2010). Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. Journal of Thrombosis and Haemostasis. 8(7). 1515–1523. 91 indexed citations
15.
Cheng, Ching‐Lan, et al.. (2010). Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiology and Drug Safety. 20(3). 236–242. 1156 indexed citations breakdown →
16.
Lin, Li-Jen, et al.. (2008). Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation—A nationwide descriptive study in Taiwan. Clinical Therapeutics. 30(9). 1726–1736. 121 indexed citations
17.
Cheng, Ching‐Lan, Shiing-Shen Chern, Qing Chen, & Fuchang Lin. (2006). Estimation of Transformer Inrush Current under Harmonic Source. 1081–1087.
18.
Cheng, Ching‐Lan, et al.. (2006). Effect of Non-Sinusoidal Excitation to Inrush Current for Transformer. 1–6. 1 indexed citations
19.
Cheng, Ching‐Lan & Chin E. Lin. (2003). A new scheme of protective system for three-phase transformers. IEEE PES Transmission and Distribution Conference and Exhibition. 3. 1808–1813. 3 indexed citations
20.
Lin, Chin E., Ching‐Lan Cheng, & Chih‐Ling Huang. (1991). Hysteresis characteristic analysis of transformer under different excitations using real time measurement. IEEE Transactions on Power Delivery. 6(2). 873–879. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026